|
1
|
Venook AP, Papandreou C, Furuse J and de
Guevara LL: The incidence and epidemiology of hepatocellular
carcinoma: a global and regional perspective. Oncologist. 15:(Suppl
4). 5–13. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou L, Liu J and Luo F: Serum tumor
markers for detection of hepatocellular carcinoma. World J
Gastroenterol. 12:1175–1181. 2006.PubMed/NCBI
|
|
3
|
Spangenberg HC, Thimme R and Blum HE:
Serum markers of hepatocellular carcinoma. Semin Liver Dis.
26:385–390. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nikolovska-Coleska Z, Meagher JL, Jiang S,
et al: Interaction of a cyclic, bivalent smac mimetic with the
x-linked inhibitor of apoptosis protein. Biochemistry.
47:9811–9824. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lens SM, Rodriguez JA, Vader G, et al:
Uncoupling the central spindle-associated function of the
chromosomal passenger complex from its role at centromeres. Mol
Biol Cell. 17:1897–1909. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vischioni B, van der Valk P, Span SW, et
al: Expression and localization of inhibitor of apoptosis proteins
in normal human tissues. Hum Pathol. 37:78–86. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ito T, Shiraki K, Sugimoto K, et al:
Survivin promotes cell proliferation in human hepatocellular
carcinoma. Hepatology. 31:1080–1085. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang Y, Zhu J, Gou H, et al: Clinical
significance of Cox-2, Survivin and Bcl-2 expression in
hepatocellular carcinoma (HCC). Med Oncol. 28:796–803. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu H, Chen XP, Zhang WG, et al:
Expression and significance of new inhibitor of apoptosis protein
survivin in hepatocellular carcinoma. World J Gastroenterol.
11:3855–3859. 2005.PubMed/NCBI
|
|
10
|
Hui WT, Zan Y, Wang XJ, et al: Expression
of survivin, p53 and its relationship with apoptosis, proliferation
in hepatocellular carcinoma (HCC). JNMU. 22:255–259. 2008.
|
|
11
|
Chau GY, Lee AF, Tsay SH, et al:
Clinicopathological significance of survivin expression in patients
with hepatocellular carcinoma. Histopathology. 51:204–218. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Augello C, Caruso L, Maggioni M, et al:
Inhibitors of apoptosis proteins (IAPs) expression and their
prognostic significance in hepatocellular carcinoma. BMC Cancer.
9:1252009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
El-Attar HA, Kandil MH, El-Kerm YM and
El-Ghandour MK: Comparison of serum survivin and alpha fetoprotein
in Egyptian patients with hepatocellular carcinoma associated with
hepatitis C viral infection. Asian Pac J Cancer Prev. 11:897–903.
2010.PubMed/NCBI
|
|
14
|
Matteucci C, Sorrentino R, Bellis L, et
al: Detection of high levels of Survivin-immunoglobulin M immune
complex in sera from hepatitis C virus infected patients with
cirrhosis. Hepatol Res. 44:1008–1018. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bruix J and Sherman M: Practice Guidelines
Committee, American Association for the Study of Liver Diseases:
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Llovet JM, Brú C and Bruix J: Prognosis of
hepatocellular carcinoma: the BCLC staging classification. Semin
Liver Dis. 19:329–338. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moon WS and Tarnawski AS: Nuclear
translocation of survivin in hepatocellular carcinoma: a key to
cancer cell growth? Hum Pathol. 34:1119–1126. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takashima H, Nakajima T, Moriguchi M, et
al: In vivo expression patterns of survivin and its splicing
variants in chronic liver disease and hepatocellular carcinoma.
Liver Int. 25:77–84. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Morinaga S, Nakamura Y, Ishiwa N, et al:
Expression of survivin mRNA associates with apoptosis,
proliferation and histologically aggressive features in
hepatocellular carcinoma. Oncol Rep. 12:1189–1194. 2004.PubMed/NCBI
|
|
20
|
Montorsi M, Maggioni M, Falleni M, et al:
Survivin gene expression in chronic liver disease and
hepatocellular carcinoma. Hepatogastroenterology. 54:2040–2044.
2007.PubMed/NCBI
|
|
21
|
Zhang JY, Megliorino R, Peng XX, et al:
Antibody detection using tumor-associated antigen mini-array in
immunodiagnosing human hepatocellular carcinoma. J Hepatol.
46:107–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Megliorino R, Shi FD, Peng XX, et al:
Autoimmune response to anti-apoptotic protein survivin and its
association with antibodies to p53 and c-myc in cancer detection.
Cancer Detect Prev. 29:241–248. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yagihashi A, Asanuma K, Kobayashi D, et
al: Autoantibodies to survivin in patients with chronic hepatitis
and hepatocellular carcinoma. Autoimmunity. 38:445–448. 2005.
View Article : Google Scholar : PubMed/NCBI
|
